Subscribe to RSS
DOI: 10.1055/s-0042-1760313
Imaging Recommendations for Diagnosis, Staging, and Management of Bone Tumors
Abstract
Primary bone sarcomas account for less than 1% of diagnosed cancers each year. In this era of multiplanar and functional imaging, the approach to the radiographic diagnosis of bone cancers goes much beyond traditional radiography. Radiographs are still the most pertinent part of the initial diagnosis of bone tumors. Multimodal imaging, such as computed tomography (CT) and magnetic resonance imaging (MRI), can help with issues such as complex anatomy, marrow assessment, soft assessment, and better local staging. The emerging imaging modality such as positron emission tomography (PET)-CT/PET-MRI has further transformed the imaging of bone malignancies. Radiologist plays an important role in the workup, staging, and management of bone tumors. The purpose of this article is to review imaging recommendations for better diagnosis, staging, and management of bone tumors.
The article is not under consideration for publication elsewhere. Each author participated sufficiently for the work to be submitted. The publication is approved by all authors.
Publication History
Article published online:
04 May 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 American Cancer Society. (cancer.org): Bone Cancer Causes, Risk Factors, and Prevention. https://www.cancer.org/cancer/bone-cancer/causes-risks-prevention/risk-factors.html
- 2 Savage SA, Mirabello L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011; 2011: 548151
- 3 Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget's disease of bone. J Bone Miner Res 2006; 21 (Suppl. 02) 58-63
- 4 Letson GD, Muro-Cacho CA. Genetic and molecular abnormalities in tumors of the bone and soft tissues. Cancer Contr 2001; 8 (03) 239-251
- 5 Franchi A. Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab 2012; 9 (02) 92-95
- 6 Ramaswamy A, Rekhi B, Bakhshi S, Hingmire S, Agarwal M. Indian data on bone and soft tissue sarcomas: a summary of published study results. South Asian J Cancer 2016; 5 (03) 138-145
- 7 George A, Grimer R. Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?. Ann R Coll Surg Engl 2012; 94 (04) 261-266
- 8 Salom M, Chiari C, Alessandri JMG, Willegger M, Windhager R, Sanpera I. Diagnosis and staging of malignant bone tumours in children: what is due and what is new?. J Child Orthop 2021; 15 (04) 312-321
- 9 Baptista AM, Zumárraga JP, Dos Santos RP, Haubert GO, de Camargo OP. Serum values of alkaline phosphatase and lactate dehydrogenase in EWING'S SARCOMA. Acta Ortop Bras 2016; 24 (04) 196-199
- 10 Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clinic Proceedings. Vol. 91, Elsevier January 1: 2016: 101-119
- 11 Zucman J, Delattre O, Desmaze C. et al. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer 1992; 5 (04) 271-277
- 12 Goyal N, Kalra M, Soni A, Baweja P, Ghonghe NP. Multi-modality imaging approach to bone tumors - state-of-the art. J Clin Orthop Trauma 2019; 10 (04) 687-701
- 13 Costelloe CM, Madewell JE. Radiography in the initial diagnosis of primary bone tumors. AJR Am J Roentgenol 2013; 200 (01) 3-7
- 14 Golfieri R, Baddeley H, Pringle JS, Leung AW, Greco A, Souhami R. MRI in primary bone tumors: therapeutic implications. Eur J Radiol 1991; 12 (03) 201-207
- 15 Jelinek JS, Murphey MD, Welker JA. et al. Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors. Radiology 2002; 223 (03) 731-737
- 16 Stacy GS, Mahal RS, Peabody TD. Staging of bone tumors: a review with illustrative examples. AJR Am J Roentgenol 2006; 186 (04) 967-976
- 17 Costelloe CM, Chuang HH, Madewell JE. FDG PET/CT of primary bone tumors. AJR Am J Roentgenol 2014; 202 (06) W521-31
- 18 Hayashida Y, Yakushiji T, Awai K. et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 2006; 16 (12) 2637-2643
- 19 Bestic JM, Wessell DE, Beaman FD. et al; Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® primary bone tumors. J Am Coll Radiol 2020; 17 (5S): S226-S238
- 20 Jaffe N. Chemotherapy for malignant bone tumors. Orthop Clin North Am 1989; 20 (03) 487-503
- 21 Strauss SJ, Frezza AM, Abecassis N. et al; ESMO Guidelines Committee, EURACAN, GENTURIS and ERN PaedCan. Electronic address: clinicalguidelines@esmo.org. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2021; 32 (12) 1520-1536
- 22 National Comprehensive Cancer Network. 2021 Bone cancer (version.2.2022). Accessed December 13, 2022, at: https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf
- 23 Puri A, Ranganathan P, Gulia A, Crasto S, Hawaldar R, Badwe RA. Does a less intensive surveillance protocol affect the survival of patients after treatment of a sarcoma of the limb? Updated results of the randomized TOSS study. Bone Joint J 2018; 100-B (02) 262-268